Laboratory of Pharmacology and Toxicology, Department of Pathobiology, Pharmacology and Zoological Medicine, Faculty of Veterinary Medicine, Ghent University, B-9820 Merelbeke, Belgium.
Institute of Health, School of Pharmacy, Jimma University, Jimma P.O. Box 378, Ethiopia.
Molecules. 2022 Feb 1;27(3):998. doi: 10.3390/molecules27030998.
A fast, accurate and reliable ultra-high performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) method was developed for simultaneous quantification of ivermectin (IVER), doramectin (DORA), and moxidectin (MOXI) in bovine plasma. A priority for sample preparation was the eradication of possible infectious diseases to avoid travel restrictions. The sample preparation was based on protein precipitation using 1% formic acid in acetonitrile, followed by Ostro 96-well plate pass-through sample clean-up. The simple and straightforward procedure, along with the short analysis time, makes the current method unique and suitable for a large set of sample analyses per day for PK studies. Chromatographic separation was performed using an Acquity UPLC HSS-T3 column, with 0.01% acetic acid in water and methanol, on an Acquity H-Class ultra-high performance liquid chromatograph (UHPLC) system. The MS/MS instrument was a Xevo TQ-S mass spectrometer, operating in the positive electrospray ionization mode and two multiple reaction monitoring (MRM) transitions were monitored per component. The MRM transitions of / 897.50 > 753.4 for IVER, / 921.70 > 777.40 for DORA and / 640.40 > 123.10 for MOXI were used for quantification. The method validation was performed using matrix-matched calibration curves in a concentration range of 1 to 500 ng/mL. Calibration curves fitted a quadratic regression model with 1/x2 weighting (r ≥ 0.998 and GoF ≤ 4.85%). Limits of quantification (LOQ) values of 1 ng/mL were obtained for all the analytes, while the limits of detection (LOD) were 0.02 ng/mL for IVER, 0.03 ng/mL for DORA, and 0.58 ng/mL for MOXI. The results of within-day (RSD < 6.50%) and between-day (RSD < 8.10%) precision and accuracies fell within acceptance ranges. No carry-over and no peak were detected in the UHPLC-MS/MS chromatogram of blank samples showing good specificity of the method. The applicability of the developed method was proved by an analysis of the field PK samples.
建立了一种快速、准确、可靠的超高效液相色谱-串联质谱(UHPLC-MS/MS)法,用于同时定量检测牛血浆中的伊维菌素(IVER)、多拉菌素(DORA)和莫昔克丁(MOXI)。样品制备的首要任务是消除可能的传染病,以避免旅行限制。样品制备基于使用 1%甲酸在乙腈中的蛋白质沉淀,然后进行 Ostro 96 孔板穿透式样品净化。该方法简单直接,分析时间短,使其成为独特的方法,适用于每天进行大量的 PK 研究样品分析。色谱分离在 Acquity UPLC HSS-T3 柱上进行,采用 0.01%乙酸水溶液和甲醇作为流动相,在 Acquity H-Class 超高效液相色谱(UHPLC)系统上进行。MS/MS 仪器为 Xevo TQ-S 质谱仪,采用正电喷雾电离模式,每个成分监测两个多重反应监测(MRM)转换。IVER 的 / 897.50 > 753.4、DORA 的 / 921.70 > 777.40 和 MOXI 的 / 640.40 > 123.10 作为定量的 MRM 转换。使用基质匹配校准曲线在 1 至 500 ng/mL 的浓度范围内进行方法验证。校准曲线拟合二次回归模型,权重为 1/x2(r ≥ 0.998,GoF ≤ 4.85%)。所有分析物的定量下限(LOQ)值均为 1 ng/mL,而伊维菌素的检测限(LOD)为 0.02 ng/mL,多拉菌素的 LOD 为 0.03 ng/mL,莫昔克丁的 LOD 为 0.58 ng/mL。日内(RSD < 6.50%)和日间(RSD < 8.10%)精密度和准确度的结果均在可接受范围内。空白样品的 UHPLC-MS/MS 色谱图中未检测到拖尾和峰,表明方法具有良好的特异性。该方法的适用性通过对现场 PK 样品的分析得到了证明。